Growth Metrics

Armata Pharmaceuticals (ARMP) Revenue (2016 - 2020)

Quarterly results put Revenue at $31000.0 for Q2 2020, changed N/A from a year ago — trailing twelve months through Jun 2020 was $117000.0 (changed N/A YoY), and the annual figure for FY2017 was $115000.0, down 55.77%.

Armata Pharmaceuticals has reported Revenue over the past 6 years, most recently at $31000.0 for Q2 2020.

  • Revenue reached $31000.0 in Q2 2020 per ARMP's latest filing, up from $20000.0 in the prior quarter.
  • Across five years, Revenue topped out at $106000.0 in Q1 2016 and bottomed at $20000.0 in Q4 2017.
  • Median Revenue over the past 3 years was $29000.0 (2016), compared with a mean of $45111.1.
  • The largest annual shift saw Revenue plummeted 82.81% in 2016 before it surged 31.03% in 2017.
  • Over 3 years, Revenue stood at $22000.0 in 2016, then decreased by 9.09% to $20000.0 in 2017, then surged by 55.0% to $31000.0 in 2020.
  • Business Quant data shows Revenue for ARMP at $31000.0 in Q2 2020, $20000.0 in Q4 2017, and $38000.0 in Q3 2017.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn - -
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn - -
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn 306.30 Mn
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - -
5 Akari Therapeutics 605.66 Bn 605.66 Bn - -
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn 2.99 Bn
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn 3.61 Bn
8 Evaxion A 65.12 Bn 65.10 Bn - -
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn 1.17 Bn
10 Armata Pharmaceuticals 301.92 Mn 297.17 Mn - -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2020 31,000.00
Dec 31, 2017 20,000.00
Sep 30, 2017 38,000.00
Jun 30, 2017 28,000.00
Mar 31, 2017 29,000.00
Dec 31, 2016 22,000.00
Sep 30, 2016 29,000.00
Jun 30, 2016 103,000.00